2m 2m 2m 2m 2m 2m 2m
Spyre Therap (SYRE)
NASDAQ
$88.66-$11.66 (-11.63%)
Price as of Jun 23, 2026 4:59 PM EDT- $8.7BMarket Cap
- 583.38%1-Year Change
- BiotechnologyIndustry
Spyre Therap (SYRE)
$88.66-$11.66 (-11.63%)
SYRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $100.32 | ||
Change | +$11.98 (+13.56%) | ||
Open | $95.00 | ||
High | $101.70 | ||
Low | $95.00 | ||
Previous Close | $88.34 | ||
Volume | 2,805,255 | ||
30-Day Average Volume | 1,250,120 | ||
1-Week Change | 20.03% | ||
1-Month Change | 35.48% | ||
1-Year Change | 583.38% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 86.8M | ||
Total Assets | $764.0M | ||
Market Cap | $8.7B | ||
Enterprise Value | $8.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$69.0M | ||
Free Cash Flow | -$57.4M | ||
EBIT | -$69.0M | ||
EBITDA | -$69.0M | ||
Net Working Capital | $678.8M | ||
EPS | -$29.66 | ||
Enterprise Value/EBITDA | -125 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 13 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -152 | ||
Price/Operating Cash Flow | -152 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/08/2023 | ||
Earnings & Revenue